Latest Ratios: P/E Ratio 11.8x · EV/EBITDA 9.9x · ROE 4.8%. (2015–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $405M | $520M | $712M | $624M | $395M | $501M | $403M | — | — | — | — |
| Enterprise Value | $1.3B | $1.4B | $1.6B | $1.5B | $1.0B | $1.1B | $873M | — | — | — | — |
| P/E Ratio → | 11.83 | 15.11 | 9.66 | 7.46 | 25.56 | 5.99 | 7.36 | — | — | — | — |
| P/S Ratio | 2.60 | 3.33 | 5.00 | 4.24 | 7.58 | 4.96 | 6.50 | — | — | — | — |
| P/B Ratio | 0.58 | 0.74 | 0.96 | 0.84 | 0.64 | 0.77 | 0.72 | — | — | — | — |
| P/FCF | 5.42 | 6.97 | 8.61 | 10.10 | 6.76 | 17.61 | — | — | — | — | — |
| P/OCF | 5.42 | 6.97 | 8.61 | 10.10 | 6.76 | 17.61 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.89 | 11.08 | 9.92 | 20.01 | 11.10 | 14.08 | — | — | — | — |
| EV / EBITDA | 9.92 | 10.82 | 21.11 | 17.38 | 63.18 | 12.86 | 15.76 | — | — | — | — |
| EV / EBIT | 10.71 | 14.84 | 21.11 | 17.38 | 63.18 | 12.86 | 15.76 | — | — | — | — |
| EV / FCF | — | 18.59 | 19.07 | 23.64 | 17.86 | 39.44 | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 78.0% | 58.6% | 62.8% | 44.5% | 84.0% | 78.4% | 67.7% | 50.1% | 72.7% | 88.7% |
| Operating Margin | 76.1% | 76.1% | 52.5% | 57.1% | 31.7% | 86.3% | 89.3% | 79.4% | 55.3% | 59.0% | 69.1% |
| Net Profit Margin | 22.1% | 22.1% | 51.7% | 56.9% | 29.8% | 82.7% | 88.2% | 78.4% | 54.0% | 57.4% | 69.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 4.8% | 4.8% | 9.9% | 12.4% | 2.5% | 13.8% | 11.3% | 6.6% | 2.0% | 2.9% | 6.0% |
| ROA | 2.1% | 2.1% | 4.5% | 5.7% | 1.2% | 7.1% | 6.1% | 4.7% | 1.9% | 3.3% | 6.4% |
| ROIC | 5.6% | 5.6% | 3.5% | 4.4% | 1.0% | 5.7% | 4.7% | 3.1% | 1.1% | 1.8% | 4.0% |
| ROCE | 7.4% | 7.4% | 4.6% | 5.9% | 1.3% | 7.5% | 6.3% | 4.8% | 2.0% | 3.4% | 6.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.24 | 1.18 | 1.14 | 1.07 | 0.97 | 0.84 | 0.79 | 0.49 | 0.48 | 0.00 |
| Debt / EBITDA | 6.80 | 6.80 | 11.72 | 10.04 | 39.65 | 7.23 | 8.52 | 10.86 | 28.32 | 16.22 | 0.00 |
| Net Debt / Equity | — | 1.23 | 1.17 | 1.13 | 1.06 | 0.95 | 0.84 | 0.78 | 0.46 | 0.45 | -0.02 |
| Net Debt / EBITDA | 6.77 | 6.77 | 11.58 | 9.95 | 39.26 | 7.11 | 8.48 | 10.71 | 27.07 | 15.23 | -0.43 |
| Debt / FCF | — | 11.63 | 10.46 | 13.54 | 11.10 | 21.82 | — | 10.75 | — | — | — |
| Interest Coverage | 1.63 | 1.63 | 1.27 | 1.53 | 0.57 | 5.40 | 4.13 | 2.46 | 1.11 | 2.16 | 6.14 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | 0.14 | 1.44 | 0.84 | 1.01 | 1.44 | 0.95 | 0.99 | 1.10 | 999999.00 | 1.99 |
| Quick Ratio | 0.14 | 0.14 | 1.44 | 0.84 | 1.01 | 1.44 | 0.95 | 0.99 | 1.10 | 999999.00 | 1.99 |
| Cash Ratio | 0.14 | 0.14 | 0.26 | 0.30 | 0.18 | 0.31 | 0.09 | 0.26 | 1.02 | 1.50 | 1.33 |
| Asset Turnover | — | 0.10 | 0.09 | 0.09 | 0.04 | 0.08 | 0.06 | 0.05 | 0.03 | 0.05 | 0.08 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 16.6% | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | 196.5% | 196.5% | — | — | — | — | 78.0% | — | 166.2% | 91.1% | 45.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.5% | 6.6% | 10.4% | 13.4% | 3.9% | 16.7% | 13.6% | — | — | — | — |
| FCF Yield | 18.4% | 14.4% | 11.6% | 9.9% | 14.8% | 5.7% | — | — | — | — | — |
| Buyback Yield | 0.3% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 17.0% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $37M | $37M | $36M | $31M | $28M | $28M | $28M | $30M | $30M | $6M |
NAV Erosion and Leverage
According to current market data, CCAP trades at a P/B ratio of 0.58, which, when compared to peers like Ares Capital, suggests that investors are pricing in significant skepticism regarding the ultimate realizable value of the underlying loan portfolio and potential future NAV impairment.
The forward P/E of 7.12 appears to imply a market expectation of earnings contraction rather than growth, likely driven by the recent volatility in net margins. This valuation discount warrants investigation into whether the market is over-penalizing the firm for temporary mark-to-market adjustments or correctly identifying structural credit deterioration.
As reported in financial statements, CCAP's ROIC has trended downward from 1.5% in 2023Q4 to -0.1% in 2026Q1, indicating that the firm is struggling to generate positive returns on its invested capital as portfolio valuations face persistent downward pressure.
The decline in ROIC suggests that the firm's underwriting discipline may be failing to offset the impact of rising non-accruals or valuation write-downs. Investors should monitor whether this decay is a temporary byproduct of the current credit cycle or a permanent shift in the firm's ability to source high-quality, yield-accretive assets.
Based on recent quarterly filings, CCAP's debt-to-equity ratio has risen to 1.35x, which, when viewed alongside a shrinking equity base, suggests that the firm is operating with a diminishing cushion to absorb further portfolio losses before hitting regulatory or covenant-based leverage limits.
The increase in leverage during a period of negative net margins indicates a reliance on debt to maintain dividend distributions or fund operations. This trend is particularly concerning given the low interest coverage ratio of -0.09, which suggests that debt service capacity is becoming increasingly fragile.
According to the provided balance sheet data, the current ratio has plummeted to 0.14 in 2025Q4, signaling that the firm's short-term liquidity position is insufficient to cover immediate obligations without relying on external credit facility access or asset liquidations.
This liquidity profile appears highly vulnerable to market stress, as the firm lacks the current assets to comfortably manage its short-term liabilities. The lack of a robust liquidity buffer suggests that any further disruption in credit markets could force the firm into unfavorable financing decisions or asset sales.
Based on an analysis of BDC business models, the P/E ratio is frequently misapplied to CCAP because it fails to account for the non-cash fair value adjustments that heavily distort net income, obscuring the underlying cash-generating durability of the firm's net investment income.
Investors should prioritize Net Investment Income (NII) and NAV per share over traditional P/E multiples to better assess the firm's true earning power. Relying on P/E in this context may lead to a 'value trap' conclusion, as it ignores the potential for recovery in the underlying loan book.
Includes 30+ ratios · 11 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CCAP stock.
Crescent Capital BDC, Inc.'s current P/E ratio is 11.8x. The historical average is 11.9x. This places it at the 67th percentile of its historical range.
Crescent Capital BDC, Inc.'s current EV/EBITDA is 9.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.5x.
Crescent Capital BDC, Inc.'s return on equity (ROE) is 4.8%. The historical average is 6.3%.
Based on historical data, Crescent Capital BDC, Inc. is trading at a P/E of 11.8x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Crescent Capital BDC, Inc.'s current dividend yield is 16.64% with a payout ratio of 196.5%.
Crescent Capital BDC, Inc. has 78.0% gross margin and 76.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Crescent Capital BDC, Inc.'s Debt/EBITDA ratio is 6.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.